Back

Predictions of adverse outcomes using different renal function estimation formulas in patients with atrial fibrillation receiving direct oral anticoagulants

30 August 2026 (12:15 - 13:00)
Organised by: Logo
Congress Presentation Part of: Epidemiology, prognosis, and outcomes in atrial fibrillation Clinical ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Tze-Fan Chao

Taipei Veterans General Hospital, Taipei (Taiwan)

6 More presentations in this session

Presentation thumbnail
Association between biological aging acceleration and adverse cardiovascular prognosis in atrial fibrillation patients: a multicenter real-world cohort study
Professor T. Liu (Tianjin, CN)
Abstract
Presentation thumbnail
Integrated care improves outcomes in multimorbid patients with atrial fibrillation: insights from the MIRACLE-AF trial
Doctor M. Li (Nanjing, CN)
Abstract
Presentation thumbnail
Renal function and outcomes in subclinical atrial fibrillation: a prespecified analysis of the ARTESIA trial
Doctor R. Reddy (Durham, US)
Abstract
Presentation thumbnail
Primary care physician continuity improve survival in patients with atrial fibrillation: a retrospective analysis of 15,000 patients with atrial fibrillation
Professor J. Gonzalez Juanatey (Santiago de Compostela, ES)
Abstract
Presentation thumbnail
Early electrical cardioversion for early recurrent atrial tachyarrhythmia after pulmonary vein isolation in atrial fibrillation: a global real-world analysis
Miss L. Serio (L'Aquila, IT)
Abstract

Access the full session

Session thumbnail
Epidemiology, prognosis, and outcomes in atrial fibrillation

The Event

Event poster

ESC Congress 2026

30 August 2026 12:15 CET
You may be interested in
thumbnail
Congress Presentation
Comparison of equations for renal function assessment and major adverse outcomes in atrial fibrillation: an analysis from the EORP-AF long-term general registry
2 September 2019
thumbnail
Congress Presentation
Impact of disease stage on performance of strain markers for prediction of atrial fibrillation
3 September 2019
thumbnail
Congress Presentation
Prevalence and predictors of inappropriate DOAC prescription on first attendance at a dedicated atrial fibrillation clinic
27 August 2021
thumbnail
Congress Session
Heart failure, chronic kidney disease, and beyond: understanding risk, prognosis, and outcomes
19 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources